BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Hippocampus
,
Neocentromeres
,
Aspirin
,
rs7903146
,
TGFB1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nerve growth factor signaling pathway
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Aorta
Saphenous vein
Midbrain
Amygdala
Dorsal root ganglia
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Alpha-1-antitrypsin deficiency
Vesicular stomatitis Indiana virus disease
Disorder of digestive system
Smoker
Pyloric ulcer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
N-(5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)pyrimidin-4-yl)-N'-propylaminosulfonamide
flavopiridol
CGP 60474
Glesatinib
AZD8055
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CCDC170
ZNF112
PPP2R2C
KTN1
CCDC170
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for nerve growth factor signaling pathway
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG)
Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
Vagal Nerve Stimulation for Intestinal Barrier Dysfunction in Healthy Volunteers
Growth Hormone Treatment in Children With Phelan McDermid Syndrome
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ